Why Catalyst Pharmaceuticals Shares Are Popping Off

Catalyst Pharmaceuticals Inc. CPRX shares are trading higher by 6.40% to $16.12 Tuesday after it was announced the company will join the S&P SmallCap 600.

Catalyst Pharmaceuticals will replace Mantech International Corp. MANT in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, September 15.

The Carlyle Group Inc. CG is acquiring ManTech International in a transaction expected to be completed soon pending final conditions.

See Also: Here's How Much You'd Have Right Now If You Invested $1,000 In Apple Shares When Steve Jobs Resigned As CEO In 2011

According to data from Benzinga Pro, Catalyst Pharmaceuticals has a 52-week high of $17.22 and a 52-week low of $4.81.